OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
04955052

InkTec Co Ltd

Specialty ChemicalsVerified

InkTec maintains a debt-to-equity ratio of 0.74, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is characterized as medium, with a current ratio of 1.63, suggesting it can cover short-term obligations but with limited excess capacity. Free cash flow of KRW 5.74 billion indicates positive cash generation, though net cash is negative after subtracting total debt, signaling potential refinancing needs. Profitability metrics show a return on equity (ROE) of 3.2% and a return on assets (ROA) of 1.59%. These figures are below the typical thresholds for high-performing specialty chemical firms, suggesting that InkTec is underperforming in terms of capital efficiency and asset utilization relative to industry expectations. The company operates through four segments: Image Printing, Electronic Materials, Printing System, and Others. The Image Printing segment is the largest contributor, focusing on inks for office and industrial printers. The Electronic Materials segment provides paste inks and related components, while the Printing System segment offers UV inkjet curing printers. The Others segment includes rental income, which is a minor contributor to overall revenue. Growth trajectory is modest, with no specific numeric deltas provided for the current or next fiscal year. Historical revenue of KRW 77.53 billion reflects a stable but non-explosive growth pattern. The company's capital expenditure of KRW -1.61 billion indicates a reduction in investment, which may signal a focus on cost control or a strategic shift in capital allocation. Risk factors include medium liquidity risk and low dilution potential. The key flag of negative net cash after total debt suggests potential refinancing challenges. No dilution sources are identified in the current data, and the dilution near-term probability is assessed as low. The absence of dilution pressure is supported by the fact that shares outstanding remain unchanged between basic and diluted counts. Recent events include no specific filings or transcripts provided in the input data. The company's financial disclosures and operational updates are expected to be covered in standard quarterly and annual reports, which are not detailed in the current dataset.

30-day price · 049550+130.00 (+4.0%)
Low$3170.00High$3990.00Close$3340.00As of22 May, 00:00 UTC
Profile
CompanyInkTec Co Ltd
Ticker049550.KQ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. (unavailable from LLM output)

Classification. (unavailable from LLM output)

InkTec maintains a debt-to-equity ratio of 0.74, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is characterized as medium, with a current ratio of 1.63, suggesting it can cover short-term obligations but with limited excess capacity. Free cash flow of KRW 5.74 billion indicates positive cash generation, though net cash is negative after subtracting total debt, signaling potential refinancing needs. Profitability metrics show a return on equity (ROE) of 3.2% and a return on assets (ROA) of 1.59%. These figures are below the typical thresholds for high-performing specialty chemical firms, suggesting that InkTec is underperforming in terms of capital efficiency and asset utilization relative to industry expectations. The company operates through four segments: Image Printing, Electronic Materials, Printing System, and Others. The Image Printing segment is the largest contributor, focusing on inks for office and industrial printers. The Electronic Materials segment provides paste inks and related components, while the Printing System segment offers UV inkjet curing printers. The Others segment includes rental income, which is a minor contributor to overall revenue. Growth trajectory is modest, with no specific numeric deltas provided for the current or next fiscal year. Historical revenue of KRW 77.53 billion reflects a stable but non-explosive growth pattern. The company's capital expenditure of KRW -1.61 billion indicates a reduction in investment, which may signal a focus on cost control or a strategic shift in capital allocation. Risk factors include medium liquidity risk and low dilution potential. The key flag of negative net cash after total debt suggests potential refinancing challenges. No dilution sources are identified in the current data, and the dilution near-term probability is assessed as low. The absence of dilution pressure is supported by the fact that shares outstanding remain unchanged between basic and diluted counts. Recent events include no specific filings or transcripts provided in the input data. The company's financial disclosures and operational updates are expected to be covered in standard quarterly and annual reports, which are not detailed in the current dataset.
Key takeaways
  • InkTec maintains a moderate debt-to-equity ratio of 0.74, indicating a balanced capital structure.
  • The company's ROE of 3.2% and ROA of 1.59% suggest underperformance in capital efficiency and asset utilization.
  • Revenue is concentrated across four segments, with Image Printing and Electronic Materials being the primary contributors.
  • Free cash flow of KRW 5.74 billion indicates positive cash generation, though net cash is negative after subtracting total debt.
  • The company faces medium liquidity risk and low dilution potential, with no immediate dilution pressure.
  • --
  • **RATIONALES**:
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$77.53B
Gross profit$14.15B
Operating income$780.7M
Net income$2.51B
R&D
SG&A
D&A
SBC
Operating cash flow$682.8M
CapEx-$1.61B
Free cash flow$5.74B
Total assets$158.07B
Total liabilities$79.82B
Total equity$78.25B
Cash & equivalents$2.59B
Long-term debt$58.17B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$77.53B$780.7M$2.51B$5.74B
FY-1$73.94B$2.72B$3.08B-$21.08B
FY-2$62.81B$3.84B$3.71B-$17.03B
FY-3$61.54B$4.40B$3.96B$3.56B
FY-4$55.17B$5.66B$1.67B$2.84B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$158.07B$78.25B$2.59B
FY-1$158.90B$75.91B$2.91B
FY-2$137.23B$73.24B$5.96B
FY-3$111.95B$70.00B$3.82B
FY-4$99.42B$58.49B$837.4M
PeriodOCFCapExFCFSBC
FY0$682.8M-$1.61B$5.74B
FY-1$6.29B-$26.70B-$21.08B
FY-2$4.82B-$23.24B-$17.03B
FY-3$6.80B-$2.97B$3.56B
FY-4$7.69B-$1.33B$2.84B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$21.97B$2.18B$5.78B$6.94B
FQ-1$19.44B-$1.82B-$2.15B-$1.03B
FQ-2$18.40B-$42.6M-$987.1M$223.1M
FQ-3$17.73B$455.5M-$135.2M-$389.6M
FQ-4$19.74B-$771.5M-$475.8M-$6.90B
FQ-5$18.39B$432.3M$363.6M-$6.21B
FQ-6$18.77B$1.54B$1.78B-$3.58B
FQ-7$17.03B$1.52B$1.42B-$4.39B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$158.07B$78.25B$2.59B
FQ-1$157.59B$72.59B$1.91B
FQ-2$159.40B$74.71B$2.59B
FQ-3$160.12B$75.74B$2.03B
FQ-4$158.90B$75.91B$2.91B
FQ-5$154.65B$76.87B$5.02B
FQ-6$150.20B$76.50B$2.06B
FQ-7$143.92B$74.68B$1.87B
PeriodOCFCapExFCFSBC
FQ0$682.8M-$1.61B$6.94B
FQ-1-$1.93B-$1.57B-$1.03B
FQ-2-$1.12B-$1.46B$223.1M
FQ-3-$1.68B-$1.44B-$389.6M
FQ-4$6.29B-$26.70B-$6.90B
FQ-5$4.58B-$19.85B-$6.21B
FQ-6-$103.1M-$12.34B-$3.58B
FQ-7-$2.24B-$6.37B-$4.39B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$78.25B
Net cash-$55.59B
Current ratio1.6
Debt/Equity0.7
ROA1.6%
ROE3.2%
Cash conversion27.0%
CapEx/Revenue-2.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric049550Activity
Op margin1.0%0.4% medp25 -8.0% · p75 16.0%above median
Net margin3.2%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin18.3%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-2.1%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity74.0%59.0% medp25 54.9% · p75 72.9%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 00:54 UTC#fc3500f3
Market quoteclose KRW 3625.00 · shares 0.02B diluted
no public URL
2026-05-09 23:55 UTC#96a6315f
Source: analysis-pipeline (hybrid)Generated: 2026-05-12 00:58 UTCJob: 971a9a29